A new paper, entitled “Alzheimer disease biomarker testing in Cerebrospinal Fluid: a method to harmonize assay platforms in the absence of an absolute reference standard” was published by the founder in Clinical Chemistry.
Biomarkable
From Concept to Value – Hugo Vanderstichele
